14,8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).
Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 41 / 70
14,8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).
Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations
17 %17% of HIV-infected patients regressed ≥1 Metavir stage.
NigeriaVIH/sidapublié 2019The Journal of antimicrobial chemotherapyPubMeddocument de 8 observations
8 %Subtype G accounted for 8% of the 1442 HIV-1 pol sequences analysed.
NigeriaVIH/sidaobservé 1999-2014publié 2020Scientific reportsPubMeddocument de 6 observations
35,6 %The proportion of the association between stigma and medication adherence explained through mediation by depression was 35.6%.
Nigeriadépression · VIH/sidaobservé October 2021 to February 2022publié 2024Journal of behavioral medicinePubMeddocument de 4 observations
73,05 utility_scoreThe EQ-5D utility score of people living with HIV/AIDS on antiretroviral therapy in a Nigerian tertiary hospital was 73.05 ± 10.36.
NigeriaVIH/sidapublié 2021Value in health regional issuesPubMeddocument de 4 observations
3,38 aORFemale sex workers residing in the South East geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 3.38).
NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations
62 %In pilot mechanistic subsets, M184V mutation was present in 62% of viraemic participants.
NigeriaVIH/sidaobservé 2019–2021publié 2026Frontiers in public healthPubMeddocument de 7 observations
37,7 %37.7% of adolescents reported falling asleep as a reason for missing medications.
NigeriaVIH/sidapublié 2022AIDS carePubMeddocument de 12 observations
4,1 %HIV prevalence in Nigeria reduced from 4.1% in 2010 to 1.4% in 2019.
NigeriaVIH/sidaobservé 2010publié 2025AIDS research and therapyPubMeddocument de 4 observations
7,6 %The coinfection rate of herpes simplex virus (HSV)-1 and HSV-2 among patients with HIV in Nigeria was 7.6%.
Nigeriaherpes simplex virus (HSV)-1 · herpes simplex virus (HSV)-2 · VIH/sidaobservé 2019publié 2023BMJ openPubMeddocument de 5 observations
14 %Adverse drug reaction accounted for 14.0% (n=30) of the 215 drug therapy problems identified among PLWH in the study.
NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 11 observations
1,19 aORIncreasing symptom burden was associated with higher likelihood of retention at 12 months (adjusted odds ratio = 1.19).
NigeriaVIH/sidapublié 2020Journal of the International Association of Providers of AIDS CarePubMeddocument de 6 observations
3,7 %In a prospective observational study conducted from October 2015 to March 2016 at Imo State University Teaching Hospital Orlu, Nigeria, the HIV seroconversion rate among pregnant women who previously tested HIV negative in antenatal clinic was 3.7%.
NigeriaVIH/sidaobservé October 2015 to March 2016publié 2019Nigerian journal of clinical practicePubMeddocument de 3 observations
64,2 %Among 352 HIV-positive patients in Nigeria, 64.2% were female.
NigeriaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations
86,4 %Participants' level of knowledge of HIV/AIDS was good, at 86.4% for males and 86.3% for females.
NigeriaVIH/sidapublié 2019West African journal of medicinePubMeddocument de 7 observations
1,67 %Malaria RDT result was positive in 1/60 (1.67%) of the HIV-negative group.
Nigeriapaludisme · VIH/sidaobservé 2018–2019publié 2024BMC infectious diseasesPubMeddocument de 15 observations
2,8 %Overall HIV prevalence was 2.8% among 15,609 participants in the Akwa Ibom AIDS Indicator Survey.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations
16 %CRF43_02G accounted for 16% of the 1442 HIV-1 pol sequences analysed.
NigeriaVIH/sidaobservé 1999-2014publié 2020Scientific reportsPubMeddocument de 6 observations
503 individualsAmong 1266 respondents living with HIV who were taking antiretroviral drugs, 503 (40%) did not disclose their HIV status to interviewers in a nationally representative HIV sero-survey conducted in Nigeria in 2018.
NigeriaVIH/sidaobservé 2018publié 2023AIDS (London, England)PubMeddocument de 2 observations
24,9 %The prevalence of hypertension among people living with HIV (PLHIV) receiving care at a Nigerian hospital was 24.9%.
Nigeriahypertension artérielle · VIH/sidapublié 2022The Pan African medical journalPubMeddocument de 2 observations
2,17 odds_ratioAmong HIV-positive individuals, hypertension was associated with increased risk of prevalent chronic kidney disease, with an adjusted odds ratio of 2.17.
Nigeriahypertension artérielle · maladie rénale chronique · VIH/sidapublié 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument de 7 observations
31,8 %Among 415 people living with HIV attending a tertiary care center in Kano, Nigeria, 31.8% cited elimination of travel expenses as a primary motivation for teleconsultation acceptance.
NigeriaVIH/sidapublié 2025Telemedicine journal and e-health : the official journal of the American Telemedicine AssoPubMeddocument de 6 observations
10 timesYoung men who have sex with men (YMSM) in Nigeria are ten times more likely to be living with HIV-1 than other young men.
NigeriaVIH/sidapublié 2024AIDS and behaviorPubMeddocument de 10 observations
0,2 %LGA-level HIV prevalence in Nigeria ranged from 0.2% to 8.5% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.
NigeriaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 5 observations
45,1 %45.1% of respondents reported being exposed to the youth facilitator-driven interventions.
NigeriaVIH/sidapublié 2023PloS onePubMeddocument de 3 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.